iBio, Inc. (IBIO)

iBio, Inc. Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 28, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	28	12	18	10	58	329
Market Cap Growth	25.16%	-31.98%	77.58%	-82.21%	-82.49%	25.19%
Enterprise Value	-19	12	31	22	37	258
Last Close Price	1.23	0.76	2.11	12.20	132.00	755.00
PS Ratio	32.61	30.94	80.87	-	30.57	138.74
PB Ratio	0.44	0.83	0.85	0.67	0.91	3.03
P/TBV Ratio	0.56	1.54	1.14	1.02	0.98	3.06
EV/Sales Ratio	-	29.35	137.12	-	19.52	108.69
Debt / Equity Ratio	0.06	0.24	0.23	1.14	0.41	0.30
Asset Turnover	0.01	0.02	0.01	-	0.02	0.02
Inventory Turnover	-	-	-	-	-	3.54
Quick Ratio	8.21	1.42	3.70	0.20	1.13	14.66
Current Ratio	8.40	1.59	4.08	1.19	1.48	15.74
Return on Equity (ROE)	-54.50%	-101.52%	-84.15%	-74.33%	-34.31%	-28.11%
Return on Assets (ROA)	-28.82%	-44.79%	-29.73%	-25.58%	-15.07%	-16.05%
Return on Capital (ROIC)	-31.35%	-52.14%	-35.24%	-29.46%	-16.10%	-16.77%
Return on Capital Employed (ROCE)	-35.20%	-108.90%	-66.80%	-150.70%	-43.10%	-22.10%
Earnings Yield	-72.70%	-148.48%	-136.88%	-634.44%	-87.34%	-7.05%
FCF Yield	-62.55%	-123.78%	-103.12%	-359.78%	-77.80%	-10.63%
Buyback Yield / Dilution	-133.00%	-174.05%	-525.98%	-40.35%	-11.45%	-211.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q